Breast cancer in elderly patients over 70 years of age
Authors:
J. Gatěk 1; V. Petrů 1; P. Kosáč 1; J. Šťastný 1; M. Ratajský 1; J. Duben 1; B. Dudešek 1; M. Zábojníková 2; D. Vrána 3
Authors‘ workplace:
Chirurgické oddělení nemocnice Atlas Zlín, Univerzita Tomáše Bati ve Zlíně
1; Onkologické oddělení, Krajská nemocnice Tomáše Bati ve Zlíně
2; Onkologická klinika LF Univerzity Palackého, Olomouc
3
Published in:
Rozhl. Chir., 2018, roč. 97, č. 1, s. 11-16.
Category:
Original articles
Karcinom prsu je nejčastějším maligním onemocněním u žen. Třetina žen s karcinomem prsu je starších než 70 roků a jejich podíl se bude dále zvyšovat. Terapie vyžaduje komplexní přístup, který spojuje onkologické zásady léčby s léčbou průvodních chorob vyššího věku.
Overview
Introduction:
Breast carcinoma is the most frequent cancer in women. One third of breast cancer patients are older than 70 years and this proportion of senior patients is going to increase. Therapy must be multidisciplinary, combining the principles of cancer treatment with therapy of aging-associated diseases.
Method:
Our retrospective study assessed surgical and adjuvant therapy in female patients with breast carcinoma aged 70 years and older operated on from 1 January 2013 to 1 January 2016 at the Atlas Hospital in Zlin. 637 surgical procedures for breast carcinoma were carried out in the above period, and 239 of these patients were 70 years old or older. This subgroup represents 37.5% of all women undergoing breast surgery. A total of 66 patients (10.4%) were 80 or older.
Results:
Patients were divided into two subgroups: 70−79 years of age and 80 years of age or older. In the 70–79 subgroup, 123 (71%) breast saving surgeries, 113 (64.5%) sentinel lymph node biopsies (SLNB) and 49 (18%) axillary dissections were performed. In adjuvant therapy, a combination of radiotherapy and hormonal therapy dominated (83×) and hormonal therapy alone was administered 20×. Combinations with chemotherapy and targeted treatment were used in a minority of the cases. In the subgroup of patients older than 80 years, more mastectomies (32, accounting for 48.5%) were performed. SLNB was performed 30x (45.5%) and axillary dissection 30x (45.5%). Hormonal therapy (31x) and radiotherapy in combination with hormonal therapy (19x) were most frequently used as adjuvant therapy.
Conclusions:
Our results suggest a clear trend towards more common hormonal treatment, less chemotherapy and radiotherapy indications and more frequent mastectomy among patients aged 80 or older.
Key words:
breast carcinoma – seniors – multidisciplinary therapy
Sources
1. Dordea M, Jones R, Nicolas AP, et al. Surgery for breast cancer in the elderly-how relevant? Breast 2011;20:212−4.
2. Jemal A Siegel R Ward E, et al. Cancer statistics. Cancer J Clin 2007;57:43−66.
3. Tesarova P. Breast cancer in the elderly − should it be treated differently? Rep Pract Oncol Radiother 2013;18:26–33.
4. Dimitrakopoulos F, Kottorou A, Antonacopoulou A, et al. Early-stage breast cancer in the elderly: Confronting an old clinical problem. J Breast Cancer 2015; 18:207−17.
5. Livi L, Paiar F, Saieva C, et al. Breast cancer in the elderly: Treatment of 1500 patients. The Breast Journal 2006;12:353–9.
6. Malik M, Tartter P, Belfer R. Undertreated breast cancer in the elderly. Journal of Cancer Epidemiology 2013; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556836/.
7. Vander Waldea A, Hurriab A. Early breast cancer in the older woman. Clin Geriatr Med. 2012;28:1−18.
8. Schonberg M, Marcantonio ER, Li D et al. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;28:2038−45.
9. Vrana D, Gatek J, Lukesova L, et al. Omission of adjuvant radiation therapy in elderly patients with low risk breast cancer undergoing breast-conserving surgery – two center experience. Biomed Pap Med 2014;158:461−4.
10. Fennessy M, Bates T, MacRae K, et al. Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer. Br J Surg. 2004;91:699−704.
11. Javid S, He H, Korde L. Predictors and outcomes of completion axillary node dissection among older breast cancer patients. Ann Surg Oncol 2014;21:2172−80.
12. Krsička P, Coufal O, Zapletal O, et al. Pozitivní sentinelová uzlina u karcinomu prsu – kdy a proč doplňovat axilární disekci? Rozhl Chir 2013;92:684−9.
13. Rao VS, Jameel JK, Mahapatra TK, et al. Surgery is associated with lower morbidity and longer survival in elderly breast cancer patients over 80. Breast J 2007;13:368−73.
14. National Comprehensive Cancer Network. Breast cancer. Verze 2.2016. Available from: /www.nccn.org/professionals/physician_gls/pdf/breast.pdf [Cit. 7.7.2017]
15. Puts MT, Hardt J, Monette J, et al. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 2012;104:1133−63.
16. Van de Water W, Bastiaannet E, Scholten AN, et al. Breast-conserving surgery with or without radiotherapy in older breast patients with early stage breast cancer: a systematic review and meta-analysis. Ann Surg Oncol 2014;21:786−94.
Labels
Paediatric clinical oncology Surgery Clinical oncology Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2018 Issue 1
Most read in this issue
- Breast cancer in elderly patients over 70 years of age
- Enhanced recovery after colorectal surgery in elderly patients
- Pancreaticoduodenectomy for pancreatic cancer in elderly patients – a single-centre experience
- Pulmonary lobectomy in octogenarians with non-small cell lung cancer